GSK Pakistan
Pakistani pharmaceutical company
From Wikipedia, the free encyclopedia
GlaxoSmithKline Pakistan Limited is a Pakistani pharmaceutical company which is a subsidiary of British company GSK.[2] It is the largest pharmaceutical company in Pakistan.
 | |
| GLAXO | |
| Company type | Public |
| PSX: GLAXO KSE 100 component | |
| Industry | Pharmaceutical |
| Founded | 1951 |
| Headquarters | , Pakistan |
Area served | Pakistan |
Key people | |
| Revenue |  Rs. 41.84 billion (US$150 million)[1] (2022) |
 Rs. 5.10 billion (US$18 million)[1] (2022) | |
| Rs. 2.46 billion (US$8.8 million)[1] (2022) | |
| Total assets | Rs. 22.63 billion (US$81 million)[1] (2022) |
| Total equity | Rs. 21.05 billion (US$75 million)[1] (2022) |
Number of employees | 1,768[1] (2022) |
| Parent | GSK |
| Website | www |
History
The company started its operations in Pakistan as Glaxo Laboratories Pakistan Ltd and was listed on the Karachi Stock Exchange in 1951.[3]
GSK Pakistan equation was formed when Beecham, Glaxo Welcome and Smith Kline, all having a big name in the pharmaceutical market and that were separate entities before, merged in 2002.[4]
In December 2008, GSK Pakistan acquired operations of Bristol Myers Squibb in Pakistan for approximately US$36.5 million.[5]
In December 2010, the company acquired Stiefel Laboratories operations in Pakistan.[6]
Haleon Pakistan
In 2015, GlaxoSmithKline Consumer Healthcare Pakistan Limited (GSKCH) was demerged from GlaxoSmithKline Pakistan Limited (GLAXO).[7] In 2016, GSKCH started operations as an independent company.[7] A year later, in 2017, GSKCH got listed on PSX.[7] In 2022, GlaxoSmithKline Consumer Healthcare Pakistan Limited was renamed to Haleon Pakistan.[8]